Emily Chu Lee Wong (Emily C L Wong)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Ulcerative Colitis

Top Venues

Journal of Crohn's & colitis

Inflammatory bowel diseases

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Neeraj Narula, Hasan Hamam, Jasmine Liu, Emily Chu Lee Wong, John K Marshall, Vipul Jairath, Stephen B Hanauer, Walter Reinisch, Parambir S Dulai
Adaptive steroid tapering impedes corticosteroid-free remissions compared to forced tapering in clinical trials of ulcerative colitis. Journal of Crohn's & colitis (2024)
Sunil Sadruddin Samnani, Emily Chu Lee Wong, Hasan Hamam, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula
Outcomes of patients with prior biologic intolerance are better than those with biologic failure in clinical trials of inflammatory bowel disease. Journal of Crohn's & colitis (2024)
Emily Chu Lee Wong, Parambir S Dulai, Badar Hasan, John K Marshall, Walter Reinisch, Neeraj Narula
Combined Histologic and Endoscopic Endpoints at Post-induction Lack Additional Prognostic Value Compared to Endoscopic Improvement Alone in Ulcerative Colitis: A Post-hoc Analysis of the VARSITY study. Journal of Crohn's & colitis (2023)
Emily Chu Lee Wong, Badar Hasan, Parambir S Dulai, John K Marshall, Walter Reinisch, Neeraj Narula
End of induction patient reported outcomes predict clinical remission and endoscopic improvement with vedolizumab and adalimumab in ulcerative colitis. Scandinavian journal of gastroenterology (2022)
Emily Chu Lee Wong, Parambir S Dulai, Neeraj Narula
Correspondence on "PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system" by Gui et al . Gut (2022)
Emily Chu Lee Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula
Editorial: is it not just PROs, but the most important individual PRO, that really matters in Crohn's disease? Authors' reply. Alimentary pharmacology & therapeutics 55 (8) (2022)
Neeraj Narula, Cara Pray, Emily Chu Lee Wong, Jean Frederic Colombel, John K Marshall, Marco Daperno, Walter Reinisch, Parambir S Dulai
Categorising Endoscopic Severity of Crohn's Disease Using the Modified Multiplier SES-CD [MM-SES-CD]. Journal of Crohn's & colitis 16 (7) (2022)
Neeraj Narula, Emily Chu Lee Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch
The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn's Disease. Inflammatory bowel diseases (2022)
Emily Chu Lee Wong, Paul Moayyedi, Neeraj Narula
Beyond the White pill: Advocating for racial diversity in IBD trials. Journal of Crohn's & colitis (2022)
Emily Chu Lee Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula
Resolution of dominant patient-reported outcome at end of induction predicts clinical and endoscopic remission in Crohn's disease. Alimentary pharmacology & therapeutics 55 (9) (2022)
Cara Pray, Emily Chu Lee Wong, Achuthan Aruljothy, Parambir S Dulai, John K Marshall, Walter Reinisch, Neeraj Narula
Ulcer Size After Induction Therapy Performs Better Than Symptom Assessment for Prediction of One Year Endoscopic Remission in Crohn's Disease: A Post Hoc Analysis. Inflammatory bowel diseases (2022)
Emily Chu Lee Wong, Arif Yusuf, Jagoda Pokryszka, Parambir S Dulai, Jean Frederic Colombel, John K Marshall, Walter Reinisch, Neeraj Narula
Increased Expression of Interleukin-13 Receptor in Ileum Associated With Nonresponse to Adalimumab in Ileal Crohn's Disease. Inflammatory bowel diseases (2022)
Neeraj Narula, Achuthan Aruljothy, Emily Chu Lee Wong, Ravi Homenauth, Abdul-Aziz Alshahrani, John K Marshall, Walter Reinisch
The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies. United European gastroenterology journal 9 (5) (2021)
Neeraj Narula, Emily Chu Lee Wong, Raed AlRamdan, Hasan Bualbanat, John K Marshall, A Hillary Steinhart, Tomer Greener, Mark S Silverberg
Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti-tumor necrosis factor experienced Crohn's disease patients: A propensity-score matched cohort analysis. Journal of gastroenterology and hepatology 36 (10) (2021)
Neeraj Narula, Emily Chu Lee Wong, Jean Frederic Colombel, William J Sandborn, Marc Ferrante, John K Marshall, Walter Reinisch, Parambir S Dulai
Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for One-Year Endoscopic Remission in Moderate to Severe Crohn's Disease. Journal of Crohn's & colitis (2021)
Neeraj Narula, Emily Chu Lee Wong, Jean-Frederic Colombel, William J Sandborn, John Kenneth Marshall, Marco Daperno, Walter Reinisch, Parambir S Dulai
Predicting endoscopic remission in Crohn's disease by the modified multiplier SES-CD (MM-SES-CD). Gut (2021)